MIFEDREN Trademark

Trademark Overview

On Monday, October 18, 2004, a trademark application was filed for MIFEDREN with the United States Patent and Trademark Office. The USPTO has given the MIFEDREN trademark a serial number of 78501187. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 1, 2016. This trademark is owned by LABORATOIRES HRA - PHARMA. The MIFEDREN trademark is filed in the Pharmaceutical Products category with the following description:

Medicine for the treatment of Cushing Syndrome, which is a hyper activity of the suprarenal glands
mifedren

General Information

Serial Number78501187
Word MarkMIFEDREN
Filing DateMonday, October 18, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 1, 2016
Registration Number3626977
Registration DateTuesday, May 26, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2009

Trademark Statements

Goods and ServicesMedicine for the treatment of Cushing Syndrome, which is a hyper activity of the suprarenal glands

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRES HRA - PHARMA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75020 Paris
FR
Party NameLABORATOIRES HRA - PHARMA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75020 Paris
FR
Party NameLABORATOIRES HRA - PHARMA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75020 Paris
FR

Trademark Events

Event DateEvent Description
Friday, January 1, 2016CANCELLED SEC. 8 (6-YR)
Wednesday, March 30, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2009PUBLISHED FOR OPPOSITION
Wednesday, February 18, 2009NOTICE OF PUBLICATION
Friday, January 30, 2009NOTICE OF ALLOWANCE CANCELLED
Friday, January 30, 2009ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, January 29, 2009PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, January 29, 2009ASSIGNED TO PETITION STAFF
Tuesday, January 27, 2009PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Tuesday, January 27, 2009FAX RECEIVED
Sunday, September 21, 2008EXTENSION 5 GRANTED
Thursday, September 18, 2008EXTENSION 5 FILED
Sunday, September 21, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 18, 2008TEAS EXTENSION RECEIVED
Tuesday, May 20, 2008EXTENSION 4 GRANTED
Friday, April 25, 2008EXTENSION 4 FILED
Friday, April 25, 2008TEAS EXTENSION RECEIVED
Thursday, November 29, 2007EXTENSION 3 GRANTED
Wednesday, October 31, 2007EXTENSION 3 FILED
Wednesday, October 31, 2007TEAS EXTENSION RECEIVED
Thursday, April 26, 2007EXTENSION 2 GRANTED
Thursday, April 26, 2007EXTENSION 2 FILED
Thursday, April 26, 2007TEAS EXTENSION RECEIVED
Friday, December 8, 2006EXTENSION 1 GRANTED
Friday, October 13, 2006EXTENSION 1 FILED
Friday, October 13, 2006TEAS EXTENSION RECEIVED
Tuesday, May 2, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2006PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2006NOTICE OF PUBLICATION
Friday, December 23, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 16, 2005ASSIGNED TO LIE
Tuesday, December 13, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 18, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 18, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2005NON-FINAL ACTION MAILED
Friday, May 20, 2005NON-FINAL ACTION WRITTEN
Friday, May 20, 2005ASSIGNED TO EXAMINER
Monday, October 25, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

mifedren activity suprarenal glands hyper which treatment cushing syndrome medicine